NME1 Drives Expansion of Melanoma Cells with Enhanced Tumor Growth and Metastatic Properties

Melanoma is a lethal skin cancer prone to progression and metastasis, and resistant to therapy. Metastasis and therapy resistance of melanoma and other cancers are driven by tumor cell plasticity, largely via acquisition/loss of stem-like characteristics and transitions between epithelial and mesenc...

Full description

Saved in:
Bibliographic Details
Published in:Molecular cancer research Vol. 17; no. 8; pp. 1665 - 1674
Main Authors: Wang, Ying, Leonard, M Kathryn, Snyder, Devin E, Fisher, Matthew L, Eckert, Richard L, Kaetzel, David M
Format: Journal Article
Language:English
Published: United States 01-08-2019
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Melanoma is a lethal skin cancer prone to progression and metastasis, and resistant to therapy. Metastasis and therapy resistance of melanoma and other cancers are driven by tumor cell plasticity, largely via acquisition/loss of stem-like characteristics and transitions between epithelial and mesenchymal phenotypes (EMT/MET). NME1 is a metastasis suppressor gene that inhibits metastatic potential when its expression is enforced in melanoma and other cancers. Herein, we have unmasked a novel role for NME1 as a driver of melanoma growth distinct from its canonical function as a metastasis suppressor. NME1 promotes expansion of stem-like melanoma cells that exhibit elevated expression of stem cell markers (e.g., Sox2, Sox10, Oct-4, KLF4, and Ccnb-1), enhanced growth as melanoma spheres in culture, and enhanced tumor growth and lung colonizing activities . In contrast, NME1 expression did not affect the proliferation of melanoma cell lines in monolayer culture conditions. Silencing of NME1 expression resulted in a dramatic reduction in melanoma sphere size, and impaired tumor growth and metastatic activities of melanoma sphere cells when xenografted in immunocompromised mice. Individual cells within melanoma sphere cultures displayed a wide range of NME1 expression across multiple melanoma cell lines. Cell subpopulations with elevated NME1 expression were fast cycling and displayed enhanced expression of stem cell markers. IMPLICATIONS: Our findings suggest the current model of NME1 as a metastasis-suppressing factor requires refinement, bringing into consideration its heterogeneous expression within melanoma sphere cultures and its novel role in promoting the expansion and tumorigenicity of stem-like cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Acquisition of data: Y. Wang, M. Kathryn Leonard and D. Snyder
Analysis and interpretation of data: Y. Wang, D. Kaetzel
Writing, review, and/or revision of the manuscript: Y. Wang, M. Fisher, R. Eckert, D. Kaetzel
Conception and Design: Y. Wang, D. Kaetzel
Study supervision: D. Kaetzel
Development of methodology: Y. Wang, M. Fisher, R. Eckert, D. Kaetzel
Current address: Dr. Matthew Fisher: Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724
These authors contributed equally to the study.
ISSN:1541-7786
1557-3125
DOI:10.1158/1541-7786.MCR-18-0019